What changed
Adjusted diluted EPS of $4.15 topped the $4.07 consensus by $0.08 (+2.0%). Revenue came in at $5,274M, up 5.4% YoY (5.6% FXN), with international up 7.0% and Interventional leading segments at +7.6%. Management issued FY27 adjusted EPS guidance of $13.10–$13.30 on low single-digit reported and FXN revenue growth. The quarter's adjusted print excludes a $66M tariff refund benefit (IEEPA) and net product liability/legal charges, per the non-GAAP reconciliation.
Why it matters
Adjusted diluted EPS of $4.15 topped the $4.07 consensus by $0.08 (+2.0%). Revenue came in at $5,274M, up 5.4% YoY (5.6% FXN), with international up 7.0% and Interventional leading segments at +7.6%.